4YS1
Human Aldose Reductase complexed with a ligand with an IDD structure (2) at 1.07 A.
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | BESSY BEAMLINE 14.2 |
Synchrotron site | BESSY |
Beamline | 14.2 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2014-05-09 |
Detector | MARMOSAIC 225 mm CCD |
Wavelength(s) | 0.91841 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 49.312, 66.620, 47.309 |
Unit cell angles | 90.00, 92.15, 90.00 |
Refinement procedure
Resolution | 33.494 - 1.070 |
R-factor | 0.1324 |
Rwork | 0.132 |
R-free | 0.14840 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 2dux |
RMSD bond length | 0.005 |
RMSD bond angle | 1.264 |
Data reduction software | XDS |
Data scaling software | XDS |
Phasing software | PHASER |
Refinement software | PHENIX ((phenix.refine: 1.8.4_1492)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 50.000 | 1.130 |
High resolution limit [Å] | 1.070 | 1.070 |
Number of reflections | 131957 | |
<I/σ(I)> | 13.97 | |
Completeness [%] | 97.6 | 93.6 |
Redundancy | 3.84 | 3.57 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 5 | 291 | 50 mM di-Ammoniumhydrogen citrate pH 5.0 PEG6000= 5 % (m/V) DTT= 5.15 g/L NADP+= 0.66 g/L and Human Aldose Reductase= 15 mg/ml. Afterwards the crystals were soaked into Tris 100 mM 25% (m/V) PEG6000 pH 8.0 saturated with the inhibitor. |